AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

11,268.00p
   
  • Change Today:
      18.00p
  • 52 Week High: 12,294.00
  • 52 Week Low: 9,501.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.22m
  • Volume: 3,186,127
  • Market Cap: £174,679m
  • RiskGrade: 123

Latest ShareCast News

London close: Stocks finish lower as ECB stands pat

By Josh White

Date: Thursday 11 Apr 2024

(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.

AstraZeneca Regulatory News

Result of AGM 11-Apr-2024 17:30 RNS
AstraZeneca increases 2024 dividend by 7% 11-Apr-2024 07:00 RNS
Enhertu approved in US for HER2+ solid tumours 08-Apr-2024 07:00 RNS
Imfinzi improved OS & PFS in limited-stage SCLC 05-Apr-2024 07:00 RNS
Total Voting Rights 02-Apr-2024 15:00 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 11,268.00p
Change Today 18.00p
% Change 0.16 %
52 Week High 12,294.00
52 Week Low 9,501.00
Volume 3,186,127
Shares Issued 1,550.22m
Market Cap £174,679m
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
90.5% below the market average90.5% below the market average90.5% below the market average90.5% below the market average90.5% below the market average
92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average92.45% below the sector average
Price Trend
33.64% above the market average33.64% above the market average33.64% above the market average33.64% above the market average33.64% above the market average
75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average75.44% above the sector average
Income
86.95% below the market average86.95% below the market average86.95% below the market average86.95% below the market average86.95% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Growth
81.72% above the market average81.72% above the market average81.72% above the market average81.72% above the market average81.72% above the market average
94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average94.59% above the sector average

What The Brokers Say

Strong Buy 8
Buy 13
Neutral 6
Sell 0
Strong Sell 1
Total 28
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 22-Feb-24 10-Aug-23
Paid 25-Mar-24 11-Sep-23
Amount 197.00¢ 93.00¢

Trades for 23-Apr-2024

Time Volume / Share Price
17:33 14,272 @ 11,266.78p
17:08 2,118 @ 11,257.91p
17:07 4,644 @ 11,252.97p
17:06 990 @ 11,231.83p
16:38 3,600 @ 11,268.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page